The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis
Open accessAbstract
BACKGROUND & AIMS: Eradication of Helicobacter pylori infection has been reported to reduce the risk of gastric cancer among asymptomatic individuals in high-risk areas. The magnitude of benefit of H pylori eradication in populations with different levels of gastric cancer risk and in different clinical scenarios is unclear. We performed a systematic review and meta-analysis of randomized controlled trials and observational studies to investigate the effects of H pylori eradication on the incidence of gastric cancer. METHODS: We searched PubMed, Cochrane Library, and ClinicalTrials.gov, reviewing titles and abstracts of studies of the effects of eradication of H pylori infection on risk of gastric cancer, through May 2015. We also searched bibliographies of included studies, related reviews, and abstracts presented at Digestive Disease Week. Twenty-four eligible studies (22 research manuscripts and 2 abstracts) were included in our meta-analysis (715 incident gastric cancers among a total of 48,064 individuals/340,255 person-years). We assessed the effects, as well as their modification by baseline gastric cancer incidence, study design (randomized trial vs observational study), clinical scenario (asymptomatic infected individuals vs individuals after endoscopic resection of early gastric cancer), demographic characteristics of patients (age and sex), and duration of follow-up. RESULTS: After adjustment for baseline gastric cancer incidence, individuals with eradication of H pylori infection had a lower incidence of gastric cancer than those who did not receive eradication therapy (pooled incidence rate ratio = 0.53; 95% confidence interval: 0.44-0.64). There was little heterogeneity among studies. Baseline gastric cancer incidence modified the benefit of H pylori eradication (P = .037 for interaction); the incidence rate ratio of gastric cancer decreased in a nonlinear fashion with increasing baseline incidence of gastric cancer (P = .018, in comparison with the linear model). The benefit also modestly increased with age (P = .023 for interaction), but this might be due to correlation between age and baseline gastric cancer incidence. Eradication provided significant benefit for asymptomatic infected individuals (pooled incidence rate ratio, 0.62; 95% CI: 0.49-0.79) and individuals after endoscopic resection of gastric cancers (pooled incidence rate ratio, 0.46; 95% CI: 0.35-0.60). The benefits of H pylori eradication did not differ with study design, sex, or follow-up period. CONCLUSIONS: In a systematic review and meta-analysis, we associated eradication of H pylori infection with a reduced incidence of gastric cancer. The benefits of eradication vary with baseline gastric cancer incidence, but apply to all levels of baseline risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
Self-citationGlobal burden of cancers attributable to infections in 2008: a review and synthetic analysis
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70137-7 · Cited by 2,534
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302084 · Cited by 2,266
Self-citationBray, F., Jemal, A., Grey, N., Ferlay, J., & Forman, D. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70211-5 · Cited by 2,223
Global estimates of cancer prevalence for 27 sites in the adult population in 2008
Bray, F., Ren, J., Masuyer, E., & Ferlay, J. (2013) · International Journal of Cancer · doi:10.1002/ijc.27711 · Cited by 1,891
Kyoto global consensus report on Helicobacter pylori gastritis
Sugano, K., Tack, J., Kuipers, E. J., Graham, D. Y., El-Omar, E. M., Miura, S., Haruma, K., Asaka, M., Uemura, N., & Malfertheiner, P. (2015) · Gut · doi:10.1136/gutjnl-2015-309252 · Cited by 1,876
Self-citationWhat to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data
J. Sweeting, M., J. Sutton, A., & C. Lambert, P. (2004) · Statistics in Medicine · doi:10.1002/sim.1761 · Cited by 1,734
Wong, B. C.-Y., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H. C., Yuen, S. T., Leung, S. Y., et al. (2004) · JAMA · doi:10.1001/jama.291.2.187 · Cited by 1,435
Fukase, K., Kato, M., Kikuchi, S., Inoue, K., Uemura, N., Okamoto, S., Terao, S., Amagai, K., Hayashi, S., & Asaka, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61159-9 · Cited by 1,244
Kim, S. Y., Park, J. E., Lee, Y. J., Seo, H.-J., Sheen, S.-S., Hahn, S., Jang, B.-H., & Son, H.-J. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.09.016 · Cited by 1,165
Self-citationScreening for gastric cancer in Asia: current evidence and practice
Leung, W. K., Wu, M.-S., Kakugawa, Y., Kim, J. J., Yeoh, K.-G., Goh, K. L., Wu, K.-C., Wu, D.-C., Sollano, J., Kachintorn, U., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70072-x · Cited by 822
Self-citationCorrea, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1881 · Cited by 737
Ford, A. C., Forman, D., Hunt, R. H., Yuan, Y., & Moayyedi, P. (2014) · BMJ · doi:10.1136/bmj.g3174 · Cited by 580
Uemura, N., Mukai, T., Okamoto, S., Yamaguchi, S., Mashiba, H., Taniyama, K., Sasaki, N., Haruma, K., Sumii, K., & Kajiyama, G. (1997) · PubMed · Cited by 546
You, W.-C., Brown, L. M., Zhang, L., Li, J.-Y., Jin, M.-L., Chang, Y.-S., Ma, J.-L., Pan, K.-F., Liu, W.-D., Hu, Y., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj264 · Cited by 446
The stomach in health and disease
Hunt, R. H., Camilleri, M., Crowe, S. E., El-Omar, E. M., Fox, J. G., Kuipers, E. J., Malfertheiner, P., McColl, K. E. L., Pritchard, D. M., Rugge, M., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307595 · Cited by 403
Greenland, S. (1995) · Epidemiology · doi:10.1097/00001648-199507000-00025 · Cited by 360
Meta-analysis: Can Helicobacter pylori Eradication Treatment Reduce the Risk for Gastric Cancer?
Fuccio, L., Zagari, R. M., Eusebi, L. H., Laterza, L., Cennamo, V., Ceroni, L., Grilli, D., & Bazzoli, F. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-2-200907210-00009 · Cited by 358
Lee, Y.-C., Chen, T. H.-H., Chiu, H.-M., Shun, C.-T., Chiang, H., Liu, T.-Y., Wu, M.-S., & Lin, J.-T. (2013) · Gut · doi:10.1136/gutjnl-2012-302240 · Cited by 349
Self-citationRational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
Graham, D. Y., Lee, Y., & Wu, M. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.05.028 · Cited by 347
Self-citationChen, H.-N., Wang, Z., Li, X., & Zhou, Z.-G. (2016) · Gastric Cancer · doi:10.1007/s10120-015-0462-7 · Cited by 254
Maehata, Y., Nakamura, S., Fujisawa, K., Esaki, M., Moriyama, T., Asano, K., Fuyuno, Y., Yamaguchi, K., Egashira, I., Kim, H., et al. (2012) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2011.08.030 · Cited by 197
The biological model of gastric carcinogenesis.
Correa, P. (2004) · PubMed · Cited by 196
Effects of Helicobacter pylori Treatment on Gastric Cancer Incidence and Mortality in Subgroups
Li, W.-Q., Ma, J.-L., Zhang, L., Brown, L. M., Li, J.-Y., Shen, L., Pan, K.-F., Liu, W.-D., Hu, Y., Han, Z.-X., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju116 · Cited by 167
Wong, B. C. Y., Zhang, L., Ma, J.-L., Pan, K.-F., Li, J.-Y., Shen, L., Liu, W.-D., Feng, G.-S., Zhang, X.-D., Li, J., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300154 · Cited by 160
Choi, J., Kim, S. G., Yoon, H., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.057 · Cited by 155
Machado, A. M. D., Figueiredo, C., Touati, E., Máximo, V., Sousa, S., Michel, V., Carneiro, F., Nielsen, F. C., Seruca, R., & Rasmussen, L. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2686 · Cited by 151
Take, S., Mizuno, M., Ishiki, K., Nagahara, Y., Yoshida, T., Yokota, K., & Oguma, K. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-006-1924-9 · Cited by 141
Yanaoka, K., Oka, M., Ohata, H., Yoshimura, N., Deguchi, H., Mukoubayashi, C., Enomoto, S., Inoue, I., Iguchi, M., Maekita, T., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24591 · Cited by 137
Bae, S. E., Jung, H., Kang, J., Park, Y. S., Baek, S., Jung, J. H., Choi, J. Y., Kim, M. Y., Ahn, J. Y., Choi, K.-S., et al. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.404 · Cited by 133
Areia, M., Carvalho, R., Cadime, A. T., Gonçalves, F. R., & Dinis-Ribeiro, M. J. (2013) · Helicobacter · doi:10.1111/hel.12050 · Cited by 128
Takenaka, R., Okada, H., Kato, J., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03268.x · Cited by 125
The time to eradicate gastric cancer is now: Figure 1
Graham, D. Y., & Shiotani, A. (2005) · Gut · doi:10.1136/gut.2004.056549 · Cited by 117
Self-citationUse of Generalized Linear Mixed Models for Network Meta-analysis
Tu, Y. (2014) · Medical Decision Making · doi:10.1177/0272989x14545789 · Cited by 96
Self-citationThe Effect of Helicobacter pylori Eradication on Reducing the Incidence of Gastric Cancer
Ogura, K., Hirata, Y., Yanai, A., et al. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000248006.80699.7f · Cited by 94
Kwon, Y. H., Heo, J., Lee, H. S., Cho, C. M., & Jeon, S. W. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12633 · Cited by 69
Shiotani, A., Uedo, N., Iishi, H., Yoshiyuki, Y., Ishii, M., Manabe, N., Kamada, T., Kusunoki, H., Hata, J., & Haruma, K. (2008) · Digestion · doi:10.1159/000173719 · Cited by 66
Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: A cohort study
Kosunen, T. U., Pukkala, E., Sarna, S. J., Seppälä, K., Aromaa, A., Knekt, P., & Rautelin, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25337 · Cited by 59
Kim, Y., Choi, I. J., Kook, M., Cho, S., Lee, J. Y., Kim, C. G., Ryu, K. W., & Kim, Y. (2014) · Helicobacter · doi:10.1111/hel.12116 · Cited by 53
Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?
Mabe, K., Takahashi, M., Oizumi, H., Tsukuma, H., Shibata, A., Fukase, K., Matsuda, T., Takeda, H., & Kawata, S. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4290 · Cited by 53
Seo, J. Y., Lee, D. H., Cho, Y., Lee, D. H., Oh, H. S., Jo, H. J., Shin, C. M., Lee, S. H., Park, Y. S., Hwang, J., et al. (2013) · PubMed · doi:10.5754/hge12929 · Cited by 32
Helicobacter pylori Eradication and Metachronous Gastric Cancer
Graham, D. Y. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.10.029 · Cited by 9
Self-citation
Cited by
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
Self-citationACG Clinical Guideline: Treatment of Helicobacter pylori Infection
Chey, W. D., Leontiadis, G. I., Howden, C. W., & Moss, S. F. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.563 · Cited by 1,604
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Savoldi, A., Carrara, E., Graham, D. Y., Conti, M., & Tacconelli, E. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.007 · Cited by 1,270
Self-citationMalfertheiner, P., Camargo, M. C., El-Omar, E., Liou, J.-M., Peek, R., Schulz, C., Smith, S. I., & Suerbaum, S. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00431-8 · Cited by 1,191
Metadata
- Authors
- Lee, Y.-C., Chiang, T.-H., Chou, C.-K., Tu, Y.-K., Liao, W.-C., Wu, M.-S., & Graham, D. Y.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 150
- Issue
- 5
- Pages
- 1113-1124.e5
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2254794399
- Cited by
- 1,013
- References
- 52
- FWCI
- 19.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.